187 related articles for article (PubMed ID: 18604240)
21. Is there any relationship between pulmonary function tests and post-transplant complications of allogeneic hematopoetic stem cell transplantation?
Aydoğdu M; Ozyilmaz E; Köktürk N; Yeğin ZA; Özkurt ZN; Aki ZS; Sucak G
Minerva Med; 2012 Jun; 103(3):189-98. PubMed ID: 22653099
[TBL] [Abstract][Full Text] [Related]
22. Abnormal liver enzymes two years after haematopoietic stem cell transplantation in children: prevalence and risk factors.
Bresters D; Van Gils IC; Dekker FW; Lankester AC; Bredius RG; Schweizer JJ
Bone Marrow Transplant; 2008 Jan; 41(1):27-31. PubMed ID: 17994124
[TBL] [Abstract][Full Text] [Related]
23. The role of iron in patients after bone marrow transplantation.
de Witte T
Blood Rev; 2008 Dec; 22 Suppl 2():S22-8. PubMed ID: 19059053
[TBL] [Abstract][Full Text] [Related]
24. Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation.
Yegin ZA; Paşaoğlu H; Aki SZ; Özkurt ZN; Demirtaş C; Yağci M; Acar K; Sucak GT
Int J Lab Hematol; 2011 Aug; 33(4):414-23. PubMed ID: 21310008
[TBL] [Abstract][Full Text] [Related]
25. Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management.
Iqbal M; Creger RJ; Fox RM; Cooper BW; Jacobs G; Stellato TA; Lazarus HM
Bone Marrow Transplant; 1996 Apr; 17(4):655-62. PubMed ID: 8722371
[TBL] [Abstract][Full Text] [Related]
26. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.
Akı ŞZ; Suyanı E; Cengiz M; Özenirler S; Elbeğ Ş; Paşaoğlu H; Sucak GT
Biol Blood Marrow Transplant; 2015 May; 21(5):948-53. PubMed ID: 25681034
[TBL] [Abstract][Full Text] [Related]
27. The management of iron overload in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients: where do we stand?
Sivgin S; Eser B
Ann Hematol; 2013 May; 92(5):577-86. PubMed ID: 23430087
[TBL] [Abstract][Full Text] [Related]
28. Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation.
Sivgin S; Baldane S; Deniz K; Zararsiz G; Kaynar L; Cetin M; Unal A; Eser B
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S10-8. PubMed ID: 27521305
[TBL] [Abstract][Full Text] [Related]
29. Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis.
Altes A; Remacha AF; Sarda P; Sancho FJ; Sureda A; Martino R; Briones J; Brunet S; Canals C; Sierra J
Bone Marrow Transplant; 2004 Sep; 34(6):505-9. PubMed ID: 15286693
[TBL] [Abstract][Full Text] [Related]
30. Iron Overload in Survivors of Childhood Cancer.
Schempp A; Lee J; Kearney S; Mulrooney DA; Smith AR
J Pediatr Hematol Oncol; 2016 Jan; 38(1):27-31. PubMed ID: 26422286
[TBL] [Abstract][Full Text] [Related]
31. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
32. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
Najima Y; Ohashi K; Miyazawa M; Nakano M; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
Am J Hematol; 2009 May; 84(5):298-301. PubMed ID: 19338041
[TBL] [Abstract][Full Text] [Related]
33. Utility of liver biopsy in bone marrow transplant patients.
Chahal P; Levy C; Litzow MR; Lindor KD
J Gastroenterol Hepatol; 2008 Feb; 23(2):222-5. PubMed ID: 18289356
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
[TBL] [Abstract][Full Text] [Related]
35. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic SCT in patients with a history of invasive fungal infection.
Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M
Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496
[TBL] [Abstract][Full Text] [Related]
37. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome.
Piperno A; Vergani A; Salvioni A; Trombini P; Viganò M; Riva A; Zoppo A; Boari G; Mancia G
Liver Int; 2004 Oct; 24(5):471-6. PubMed ID: 15482345
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
Hammond SP; Borchelt AM; Ukomadu C; Ho VT; Baden LR; Marty FM
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of iron overload vs iron deficiency in multiple myeloma: resembling or different from MDS--and stem cell transplant (SCT)--patients?
König C; Kleber M; Ihorst G; Gropp A; Reinhardt H; Koch B; Wäsch R; Engelhardt M
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):671-680.e3. PubMed ID: 23932905
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity.
Roddie C; Paul JP; Benjamin R; Gallimore CI; Xerry J; Gray JJ; Peggs KS; Morris EC; Thomson KJ; Ward KN
Clin Infect Dis; 2009 Oct; 49(7):1061-8. PubMed ID: 19705974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
